Supplemental material, sj-xlsx-1-imr-10.1177_03000605211036832 for Serum levels of inhibitory costimulatory molecules and correlations with levels of innate immune cytokines in patients with pulmonary
Dupilumab is approved for multiple type 2 inflammatory diseases. In the treatment procedure, the changes of IgE levels need further analysis. We evaluated the changes of IgE levels through meta-analys
